Agresta Samuel (CIK 0001748961)

Latest company ownership

FHTX - Foghorn Therapeutics Inc.
Role: Chief Medical Officer
Shares held
376,891
Last filed at
Sep 13, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 16, 2023 Aug 18, 2023 Foghorn Therapeutics Inc. Chief Medical Officer Sell 17.5 -311,297 -100.00% ✗ $2.6M